The Health Innovation Roundup, sponsored by Health Cities, is written and published weekly by Taproot Edmonton to bring you the latest news and events in research, technology, companies and people changing health for the better in Edmonton.

Sign up to get the full edition delivered directly to your inbox. Use the code HEALTHCITY & you’ll get 10% off the first year.

Here are some highlights from this week’s Health Innovation Roundup:


        • Scandinavian Biopharma has obtained a global license for the intellectual property behind VaxAlta‘s Campylobacter jejuni — a common cause of bacterial diarrhea — vaccine. The two companies will collaborate on developing and screening new vaccine candidates for humans, and the Albertan firm may see US$102 million from the agreement.
        • As of this month, the University of Alberta Health Hub and Accelerator has been rebranded the Health Innovation Hub. “The hub will be the glue that connects the different resources available at the U of A and beyond for innovators in the human health sector,” said Paramita Chaudhuri Basu, innovation and entrepreneurship manager in the Faculty of Medicine & Dentistry. “Health innovators from anywhere in Alberta are welcome to join.” The goal is to expand from 34 to at least 50 member companies by the end of the year.
        • Around half of men will experience symptoms similar to menopause according to research out of the University of Alberta. The researchers involved also published a set of guidelines to help aging men deal with declining testosterone levels by detection with blood tests, among other methods.
        • The Alberta Cancer Foundation recently began the i-MPACT podcast, which will feature interviews with leading experts in toxicity management, long-term care, and other topics related to the disease.
        • DrugBank looked back at 2021 and how it grew in a difficult year. The company grew its team, expanded to other countries — such as Singapore, Austria, Colombia, Indonesia, Italy, Malaysia, Thailand, and Turkey — and improved its offerings.
        • Aurora Cannabis announced that it delivered $10 million of medicinal cannabis to Israel in December. The company believes this to be the largest delivery of its type in history.
        • Edify published Epidemic of Addition, about Edmonton’s opioid crisis. It’s the first part of a series on mental health.


Have a suggestion for a future edition? Send it to for consideration.

Become a “Roundup Cultivator” and sponsor Taproot Edmonton to help them chronicle health innovation in Edmonton. Learn more